Hogan Lovells US LLP
United StatesFDA applicant, unverified
- Devices
- 3
What Hogan Lovells US LLP makes
Hogan Lovells US LLP’s portfolio includes the NOVEON, a medical device designed for specific diagnostic or procedural applications, as well as the CALYPSO SYSTEM and JAZZ SYSTEM, which appear to be surgical or interventional tools for targeted procedures.
These devices fall under Class II regulation and are listed via FDA 510(k) clearance. The company is based in the United States.
Catalogue
Noveon Ref K122358
Regimes: 510(k) Registry: 510(k)Calypso System Ref K120564
Regimes: 510(k) Registry: 510(k)Jazz System Ref K132287
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Hogan Lovells US LLP have in the registry?
The registry currently lists 3 devices for Hogan Lovells US LLP. Devices recorded under merged duplicate company entries are counted once.
Which registries list Hogan Lovells US LLP's devices?
Among its 3 most recently registered devices, Hogan Lovells US LLP has devices listed in FDA 510(k) (3 devices).
What risk classes do Hogan Lovells US LLP's devices fall under?
Among its 3 most recently registered devices, the classes recorded for Hogan Lovells US LLP's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Hogan Lovells US LLP in the registry?
The most recently registered devices listed for Hogan Lovells US LLP include NOVEON, CALYPSO SYSTEM and JAZZ SYSTEM.